Clinical Trials Browser

Burkitt Lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Philadelphia Chromosome, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04685928 2025-05-06

SMART

Phase NA Completed

403 enrolled

Genitourinary

Prostatic Neoplasms

NCT06915103 2025-04-08

A Case Report of NMDAR Encephalopathy

Completed

1 enrolled

Dermoid Cyst, Paraneoplastic Syndromes, Anti-N-Methyl-D-Aspartate Receptor Encephalitis

NCT05384002 2025-04-04

An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum

Completed

14,000 enrolled

Genitourinary

Prostate Cancer, Hereditary, 7, Prostatic Neoplasms

Clinical Trials

REMASCO

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies

Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19

Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)

A Study of Patients Receiving High-Dose Rate Brachytherapy

68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)

Studying a New Piece of Equipment That Can Help Plan Radiation Therapy of the Spine

Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies

SMART

A Case Report of NMDAR Encephalopathy

An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum